Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gritstone Bio Inc (NQ: GRTS ) 0.7190 -0.0098 (-1.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Gritstone Bio Inc < Previous 1 2 Next > Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enphase, Fat Brands, Scotts, and Gritstone and Encourages Investors to Contact the Firm June 21, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS June 20, 2024 From The Rosen Law Firm PA Via GlobeNewswire Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Gritstone bio, Inc. (GRTS) June 20, 2024 From Glancy Prongay & Murray LLP Via Business Wire GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm June 19, 2024 From Schall Law Via GlobeNewswire Gritstone bio, Inc. Stockholders With Significant Losses Should Contact Robbins LLP for Information About the GRTS Class Action Lawsuit June 18, 2024 From Robbins LLP Via Business Wire GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm June 18, 2024 From The Schall Law Firm Via Business Wire Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Gritstone bio, Inc. (GRTS) June 18, 2024 From Law Offices of Howard G. Smith Via Business Wire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Scotts, and Gritstone and Encourages Investors to Contact the Firm June 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc. (GRTS) Investors June 17, 2024 From Glancy Prongay & Murray LLP Via Business Wire GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc. June 17, 2024 From Bernstein Liebhard LLP Via GlobeNewswire GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! June 17, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire GRTS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Gritstone bio, Inc. Class Action June 14, 2024 From Robbins LLP Via GlobeNewswire INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc. (GRTS) Investors June 14, 2024 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Gritstone bio, Inc. (GRTS) Investors June 13, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors June 13, 2024 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors June 12, 2024 From Law Offices of Howard G. Smith Via Business Wire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS June 12, 2024 From The Rosen Law Firm PA Via GlobeNewswire GRITSTONE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc. and Encourages Investors to Contact the Firm June 11, 2024 From Bragar Eagel & Squire Via GlobeNewswire The Law Offices of Frank R. Cruz Announces Investigation of Gritstone bio, Inc. (GRTS) on Behalf of Investors June 11, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Gritstone bio, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the GRTS Class Action June 11, 2024 From Robbins LLP Via Business Wire GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! June 11, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc. June 11, 2024 From Bernstein Liebhard LLP Via GlobeNewswire GRITSTONE INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – GRTS June 10, 2024 From The Rosen Law Firm, P.A. Via Business Wire Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against Gritstone Bio, Inc. June 08, 2024 From Robbins LLP Via GlobeNewswire Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 09, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite April 01, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates March 05, 2024 From Gritstone bio Via GlobeNewswire Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates November 08, 2023 From Gritstone bio Via GlobeNewswire Genevant Sciences LNP Technology Used in samRNA Covid-19 Vaccine Candidate Behind Gritstone bio’s BARDA Award October 12, 2023 From Genevant Sciences Via GlobeNewswire Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine October 11, 2023 From Gritstone bio Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.